Internationally recognized for his conservative management of Upper Urinary Tract Urothelial Carcinoma, Dr. Javier Aranda Pérez is a prestigious medical doctor highly qualified in the field of Urology. In this regard, his philosophy is based on providing personalized and innovative therapeutic programs to guarantee a comprehensive improvement in the quality of life of patients.

In this way, he has worked in globally renowned healthcare institutions such as the University Hospital of Cáceres. Among his main responsibilities, the leadership of multidisciplinary clinical teams stands out. He has been in charge of carrying out various surgical interventions for a wide range of pathologies, from Kidney Stones and Prostate Disorders to Complex Neoplasms of the Urinary Tract.

It should be noted that his procedures have been characterized by the use of state-of-the-art technological tools. For example, he handles instruments such as Robotic Surgery systems, high-powered Laser Lithotripsy and even Three-Dimensional Computed Tomography. By means of these minimally invasive techniques, he has been able to perform treatments with exceptional precision, reducing incisions and significantly shortening recovery times.

• Urology Specialist at the University Hospital of Cáceres
• Urologist at the University Hospital of Vinalopó

• Clinical Projects Manager at the Spanish Association of Urology

• Residency in Urology at the University Hospital of Cáceres

• PhD in Conservative Management of Urothelial Carcinoma from the University of Extremadura

• Master's Degree in Advanced Minimally Invasive Urological Surgery from the University of Extremadura

• Master's Degree in Localized, Advanced and Metastatic Prostate Cancer from the University of Salamanca

• Master's Degree in Multidisciplinary Approach to Prostate Cancer from the Complutense University of Madrid

• Master's Degree in Integration of Medical Knowledge and Clinical Problem Solving from UCAM

• Degree in Medicine from the Complutense University of Madrid

• Certification as a Fellow of the European Board of Urology